Abstract | BACKGROUND: METHODS: From January 2009 to May 2010, neoadjuvant chemotherapy was indicated in 27 patients with NSCLC (25 men, 2 women). Their mean age was 65 years. The stages were: IIB in 5, IIIA in 17 (6 in stage IIIAN2), IIIB in 2, and IV in 3. RESULTS: CONCLUSION:
|
Authors | Mohamed-Sadok Boudaya, Hanène Smadhi, Adel Marghli, Fatma Charmiti, Sonia Ouerghi, Jalel Mohamed, Emna Brahem, Belhassen Smati, Taher Mestiri, Tarek Kilani |
Journal | Asian cardiovascular & thoracic annals
(Asian Cardiovasc Thorac Ann)
Vol. 21
Issue 4
Pg. 432-6
(Aug 2013)
ISSN: 1816-5370 [Electronic] England |
PMID | 24570525
(Publication Type: Journal Article)
|
Chemical References |
- Deoxycytidine
- Vinblastine
- Cisplatin
- Vinorelbine
- Gemcitabine
|
Topics |
- Aged
- Antineoplastic Combined Chemotherapy Protocols
(therapeutic use)
- Carcinoma, Non-Small-Cell Lung
(drug therapy, pathology, surgery)
- Chemotherapy, Adjuvant
- Cisplatin
(administration & dosage)
- Deoxycytidine
(administration & dosage, analogs & derivatives)
- Disease Progression
- Female
- Humans
- Lung Neoplasms
(drug therapy, pathology, surgery)
- Male
- Middle Aged
- Neoadjuvant Therapy
- Neoplasm Staging
- Patient Selection
- Pneumonectomy
- Retrospective Studies
- Time Factors
- Treatment Outcome
- Vinblastine
(administration & dosage, analogs & derivatives)
- Vinorelbine
- Gemcitabine
|